144 related articles for article (PubMed ID: 17496250)
1. The in vivo phosphorylation and glycosylation of human insulin-like growth factor-binding protein-5.
Graham ME; Kilby DM; Firth SM; Robinson PJ; Baxter RC
Mol Cell Proteomics; 2007 Aug; 6(8):1392-405. PubMed ID: 17496250
[TBL] [Abstract][Full Text] [Related]
2. Discovery and characterization of IGFBP-mediated endocytosis in the human retinal pigment epithelial cell line ARPE-19.
Ainscough SL; Feigl B; Malda J; Harkin DG
Exp Eye Res; 2009 Nov; 89(5):629-37. PubMed ID: 19540231
[TBL] [Abstract][Full Text] [Related]
3. The effect of phosphorylation by casein kinase 2 on the activity of insulin-like growth factor-binding protein-3.
Coverley JA; Martin JL; Baxter RC
Endocrinology; 2000 Feb; 141(2):564-70. PubMed ID: 10650937
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor (IGF)-binding protein 5 forms an alternative ternary complex with IGFs and the acid-labile subunit.
Twigg SM; Baxter RC
J Biol Chem; 1998 Mar; 273(11):6074-9. PubMed ID: 9497324
[TBL] [Abstract][Full Text] [Related]
5. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix.
Arai T; Busby W; Clemmons DR
Endocrinology; 1996 Nov; 137(11):4571-5. PubMed ID: 8895319
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional evidence for the interaction of insulin-like growth factors (IGFs) and IGF binding proteins with vitronectin.
Kricker JA; Towne CL; Firth SM; Herington AC; Upton Z
Endocrinology; 2003 Jul; 144(7):2807-15. PubMed ID: 12810534
[TBL] [Abstract][Full Text] [Related]
7. O-glycosylation of insulin-like growth factor (IGF) binding protein-6 maintains high IGF-II binding affinity by decreasing binding to glycosaminoglycans and susceptibility to proteolysis.
Marinaro JA; Neumann GM; Russo VC; Leeding KS; Bach LA
Eur J Biochem; 2000 Sep; 267(17):5378-86. PubMed ID: 10951195
[TBL] [Abstract][Full Text] [Related]
8. Binding of mutants of human insulin-like growth factor II to insulin-like growth factor binding proteins 1-6.
Bach LA; Hsieh S; Sakano K; Fujiwara H; Perdue JF; Rechler MM
J Biol Chem; 1993 May; 268(13):9246-54. PubMed ID: 7683646
[TBL] [Abstract][Full Text] [Related]
9. Identification of O-glycosylation sites and partial characterization of carbohydrate structure and disulfide linkages of human insulin-like growth factor binding protein 6.
Neumann GM; Marinaro JA; Bach LA
Biochemistry; 1998 May; 37(18):6572-85. PubMed ID: 9572875
[TBL] [Abstract][Full Text] [Related]
10. Serine 204 phosphorylation and O-β-GlcNAC interplay of IGFBP-6 as therapeutic indicator to regulate IGF-II functions in viral mediated hepatocellular carcinoma.
Ahmad W; Shabbiri K; Ijaz B; Asad S; Nazar N; Nazar S; Fouzia K; Kausar H; Gull S; Sarwar MT; Shahid I; Hassan S
Virol J; 2011 May; 8():208. PubMed ID: 21548981
[TBL] [Abstract][Full Text] [Related]
11. Heparin-binding, highly basic regions within the thyroglobulin type-1 repeat of insulin-like growth factor (IGF)-binding proteins (IGFBPs) -3, -5, and -6 inhibit IGFBP-4 degradation.
Fowlkes JL; Thrailkill KM; George-Nascimento C; Rosenberg CK; Serra DM
Endocrinology; 1997 Jun; 138(6):2280-5. PubMed ID: 9165012
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-binding protein 5 complexes with the acid-labile subunit. Role of the carboxyl-terminal domain.
Twigg SM; Kiefer MC; Zapf J; Baxter RC
J Biol Chem; 1998 Oct; 273(44):28791-8. PubMed ID: 9786878
[TBL] [Abstract][Full Text] [Related]
13. Characterization of insulin-like growth factor binding protein-1 kinases from human hepatoma cells.
Ankrapp DP; Jones JI; Clemmons DR
J Cell Biochem; 1996 Mar; 60(3):387-99. PubMed ID: 8867814
[TBL] [Abstract][Full Text] [Related]
14. Mutagenesis of basic amino acids in the carboxyl-terminal region of insulin-like growth factor binding protein-5 affects acid-labile subunit binding.
Firth SM; Clemmons DR; Baxter RC
Endocrinology; 2001 May; 142(5):2147. PubMed ID: 11316783
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor (IGF)-binding protein-5-(201-218) region regulates hydroxyapatite and IGF-I binding.
Campbell PG; Andress DL
Am J Physiol; 1997 Nov; 273(5):E1005-13. PubMed ID: 9374688
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor binding protein concentration and post-translational modification in embryological fluid.
Miell JP; Jauniaux E; Langford KS; Westwood M; White A; Jones JS
Mol Hum Reprod; 1997 Apr; 3(4):343-9. PubMed ID: 9237262
[TBL] [Abstract][Full Text] [Related]
17. A central domain binding site in insulin-like growth factor binding protein-5 for the acid-labile subunit.
Twigg SM; Kiefer MC; Zapf J; Baxter RC
Endocrinology; 2000 Jan; 141(1):454-7. PubMed ID: 10614670
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs.
Oh Y; Müller HL; Lee DY; Fielder PJ; Rosenfeld RG
Endocrinology; 1993 Mar; 132(3):1337-44. PubMed ID: 7679979
[TBL] [Abstract][Full Text] [Related]
19. Substitution of specific amino acids in insulin-like growth factor (IGF) binding protein 5 alters heparin binding and its change in affinity for IGF-I response to heparin.
Arai T; Clarke J; Parker A; Busby W; Nam T; Clemmons DR
J Biol Chem; 1996 Mar; 271(11):6099-106. PubMed ID: 8626396
[TBL] [Abstract][Full Text] [Related]
20. Heparin, heparan sulfate, and dermatan sulfate regulate formation of the insulin-like growth factor-I and insulin-like growth factor-binding protein complexes.
Arai T; Parker A; Busby W; Clemmons DR
J Biol Chem; 1994 Aug; 269(32):20388-93. PubMed ID: 7519608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
